CAS-ViewAlert

View Alert


		Versions:

Originator:	DHSC & NHS England and Improvement: Supply disruption alert
Issue date:	Originally issued on 07-Nov-2019 13:23:05. This version was issued on 07-Nov-2019 13:23:05
This alert has been issued to:
	Care Trusts Mental Health Trusts Specialists Trusts NHS Regional Offices Learning Disabilities Trusts Mental Health & Social Care Trusts Ambulance Trusts Mental Health & Learning Disabilities Trusts Acute Trusts Community Trusts
	MHRA (Medicines) Drug Alerts (Various Recipients) Other contacts Independent Healthcare Providers (registered with CAS) Clinical Commissioning Groups MHRA (Medicines) Drug Alerts - Non-NHS Recipients DHSC Supply Disruption - Medicines
Action category:	Action
Title:	Mitomycin-C Kyowa all strengths - Supply Disruption Alert - Update
Broadcast content:	All unexpired batches of Kyowa Kirin Mitomycin-C are subject to a MHRA Class 2 recall EL (19)A/33. Kyowa Kirin will be unable to support the UK market for at least 12 months. UK Medicines Information, in full consultation with clinical experts in the fields of Oncology and Ophthalmology, has drafted clinical advice to support local management of this supply disruption, should sufficient imports not be available to support full demand which can be accessed via this link: https://www.sps.nhs.uk/articles/shortage-of-mitomycin-c-kyowa-all-strengths/ This is an update to SDA/2019/006, please refer to the original SDA for more information on this supply disruption.
Additional information:	NHS England Regional Offices: please do not cascade to primary care.
Alert reference:	SDA/2019/006(U)
Action underway deadline:	11-Nov-2019
Action complete deadline:	31-Jan-2020
Attachments:	SDA-2019-006-U.pdf